Matches in Nanopublications for { ?s ?p "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP26749.RA-DGchUUDIrSBbOYXulrXCQmE61NgoBfX8LLHph_OqkM130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26749.RA-DGchUUDIrSBbOYXulrXCQmE61NgoBfX8LLHph_OqkM130_provenance.
- NP26777.RAyYICJH0vpOVx6K5b9Vj00g_WSt3Vz8X6mNMzkvhoYi4130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26777.RAyYICJH0vpOVx6K5b9Vj00g_WSt3Vz8X6mNMzkvhoYi4130_provenance.
- NP26784.RA9uS4-uRvpSVJckxX1FW0GqFLJ2ZaTeo0JNh0rc882a0130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26784.RA9uS4-uRvpSVJckxX1FW0GqFLJ2ZaTeo0JNh0rc882a0130_provenance.
- NP26750.RARLLoBphEJMGXO_Bk70r0T4JXurZSVPZ2WOaSePs1dlk130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26750.RARLLoBphEJMGXO_Bk70r0T4JXurZSVPZ2WOaSePs1dlk130_provenance.
- NP26662.RAdRL23DsptkH1Tf-aB_WTRFN2a6Ws4TGLYGQ29UOcXwQ130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26662.RAdRL23DsptkH1Tf-aB_WTRFN2a6Ws4TGLYGQ29UOcXwQ130_provenance.
- NP26670.RAnTii4RM965EKO9QDiRYawP1sRPZ1AOWdGh-I9M7Z2GA130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26670.RAnTii4RM965EKO9QDiRYawP1sRPZ1AOWdGh-I9M7Z2GA130_provenance.
- assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP16280.RAsOyDoarEgh6_x88wJdI1KNtDyPedfPvZGnIpgTsjlWM130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16280.RAsOyDoarEgh6_x88wJdI1KNtDyPedfPvZGnIpgTsjlWM130_provenance.
- NP16281.RAtLkO2e_G69a-mS9ct7ymBM6UKbutdadoqpz5_BYBdJQ130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16281.RAtLkO2e_G69a-mS9ct7ymBM6UKbutdadoqpz5_BYBdJQ130_provenance.
- NP16282.RAKpkGgH93eLtkhdT5aQMYbSTgWKEudp46u9CqkaHFY_k130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16282.RAKpkGgH93eLtkhdT5aQMYbSTgWKEudp46u9CqkaHFY_k130_provenance.
- NP16279.RA2yl5PrHg60J-S0o-yWQC1l55NlicU5cfiZFQDvQxVAM130_assertion description "[Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16279.RA2yl5PrHg60J-S0o-yWQC1l55NlicU5cfiZFQDvQxVAM130_provenance.